Infosys Trims Guidance and Reports EPS Decline, Stock Drops as AI Revenue Fails to Offset Weakness
Read source articleWhat happened
Infosys released quarterly results that disappointed investors, with earnings per share declining year-over-year and management cutting full-year guidance, triggering a sell-off in the stock. The company continued to tout strong growth in AI-related revenue, but the market remains unconvinced that these AI gains can compensate for ongoing pricing pressure and soft demand in traditional IT services. This development aligns with the risks highlighted in our earlier master report, which flagged the danger of AI productivity pass-throughs eroding margins and the possibility that large-deal signings would fail to convert into billed revenue quickly enough. Key operational metrics, including utilization and headcount, had already been deteriorating, and the guidance trim suggests management's previous outlook was too optimistic. While the stock's valuation is not expensive on a P/E basis, the lack of positive catalysts and the increasing evidence of structural deflation in the industry make the risk-reward unattractive at current levels.
Implication
The guidance cut and EPS decline materially weaken the bull case that AI will drive sufficient revenue expansion to offset deflationary forces, shifting probability weight toward the bear scenario. In our base case, we had modeled FY27 growth of 2.5% constant currency and operating margin of 21%; the new information suggests growth may come in at the lower end of the previous range or below, with margin closer to 20%. Investors should focus on the next two quarterly reports for signs that utilization ex-trainees is rising above 83% and that large-deal TCV remains above $3 billion per quarter while converting into revenue. Until those metrics improve, the stock is likely to remain under pressure, and any bounce should be viewed as an opportunity to trim positions rather than add. A more attractive entry point may emerge closer to $9.00 if the bear case unfolds, but for now, the prudent action is to stay on the sidelines or reduce holdings.
Thesis delta
The original thesis recommended waiting for evidence that large-deal conversion and utilization would stabilize within FY27 guidance. The new earnings report indicates that management has trimmed guidance and EPS has declined, which increases the probability of the bear scenario where growth falls below 1.5% and margin approaches 20%. We therefore downgrade our rating from WAIT to SELL, with a revised near-term fair value of $9.00.
Confidence
High